Lead Independent Director · Axsome Therapeutics, Inc. (AXSM)

Mark Coleman director compensation at Axsome Therapeutics: $515K

Fiscal year 2025 director compensation for Mark Coleman at Axsome Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Mark Coleman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Mark Coleman and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Axsome Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Axsome Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$114,834$159,919$239,992$0$514,745
FY2024$107,830—$324,961—$432,790
FY2023$102,898—$324,943—$427,842

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Axsome Therapeutics, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177610, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Axsome Therapeutics, Inc. filed document, accession 0001193125-26-177610. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the Axsome Therapeutics Board Governance Report

$514,745 Mark Coleman, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Axsome Therapeutics pays directors a $50,000 cash retainer and $400,000 in Options and RSUs.

Committees

FY2025 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the Axsome Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Herriot TabuteauChair of the Board—
Mark SaadIndependent Director$488,107
Roger JeffsIndependent Director$482,362
Susan MahonyIndependent Director$476,470

The full Axsome Therapeutics compensation record

free company brief

This page is one director within Axsome Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Axsome Therapeutics proxy · each links to its own free brief

Order AXSM

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report